Former 1974 British Eurovision representative, Olivia Newton-John, has announced the postponement of her upcoming June concert dates following a recent breast cancer diagnosis.
Following an initial postponement of the first half of her tour earlier this year due to back pain, it has since been established that a recent cancer diagnosis has been the cause of Olivia Newton-John’s recent health problems, therefore forcing the singer to postpone her tour.
Tour dates reluctantly postponed
In a statement released via Newton-John’s official Facebook page, the former Grease and Eurovision icon confirmed her reluctance at postponing her forthcoming tour dates, adding:
I decided on my direction of therapies after consultation with my doctors and natural therapists and the medical team at my Olivia Newton-John Cancer Wellness and Research Centre in Melbourne, Australia.
For Immediate ReleaseOLIVIA NEWTON-JOHN POSTPONES JUNE CONCERT DATES May 30, 2017 – Las Vegas, NV — Olivia…
Newton-John is set to complete a course of photon radiation therapy over the coming period, with the British-Australian singer confidently hoping get back on stage for the remainder of her tour later this year.
First diagnosis and charity fundraising
Newton-John was previously diagnosed with breast cancer back in 1992, an experience which she has previously stated she has been grateful for as:
Without it I would not have done many of the things I have done in my life. It’s taught me compassion for those going through difficult times.
Following her first diagnosis, the singer has dedicated a vast amount of time towards raising money for cancer charities, including donating proceeds from her recent album releases as well as embarking on a number of adventurous fundraising events.
The Olivia Newton-John Cancer Wellness & Research Centre later went on to be founded. A collaboration between Austin Health and the Olivia Newton-John Cancer Research Institute, the ONJ Cancer Centre works on providing cancer treatment to patients as well as carrying out breakthrough research and clinical trials.